DIVERTICULAR DISEASE OF THE COLON


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Modern views on terminology, classification, etiopathogenetic mechanisms, features of the clinical manifestation and diagnosis of diverticular disease of the colon are presented. Modern approaches to the treatment and prevention of various variants of this pathology are discussed.

Full Text

Restricted Access

About the authors

E. V Skazyvaeva

FSBEI HE NWSMU n.a. I.I. Mechnikov of RMH

Email: skazyvaeva@yandex.ru
PhD, Associate Professor at the Department of Propaedeutics of Internal Diseases, Gastroenterology and Dietology

E. B Avalueva

FSBEI HE NWSMU n.a. I.I. Mechnikov of RMH

Department of Propaedeutics of Internal Diseases, Gastroenterology and Dietology

S. I Sitkin

FSBEI HE NWSMU n.a. I.I. Mechnikov of RMH

Department of Propaedeutics of Internal Diseases, Gastroenterology and Dietology

I. G Bakulin

FSBEI HE NWSMU n.a. I.I. Mechnikov of RMH

Department of Propaedeutics of Internal Diseases, Gastroenterology and Dietology

M. I Skalinskaya

FSBEI HE NWSMU n.a. I.I. Mechnikov of RMH

Department of Propaedeutics of Internal Diseases, Gastroenterology and Dietology

References

  1. Cruveilhier J. Traite d'anatomie pathologique generale. Jean Cruveilhier. A Paris: J.-B. Ballière. 1849;1:743.
  2. Graser E. Ueber multiple falsche darmdivertikel in der flexura sigmoidea. Munch. Med. Wochensch. 1899;22:721-23.
  3. Mayo W., Wilson L., Griffin H. Acquired diverticulitis of the large intestine.Surg. Gynecol. Obstet. 1907;5:8-15.
  4. Etzioni D.A., Mack T.M., Beart R.W., Kaiser A.M. Diverticulitis in the United States: 1998-2005: Changing patterns of disease and treatment.Ann. Surg. 2009;249:210-17.
  5. Strate L., Erichsen R., Baron J., Mortensen J., Pedersen J., Riis A., et al. Heritability and familial aggregation of diverticular disease: a population-based study of twins and siblings. Gastroenterology. 2013;144:736-42.
  6. Humes D., Smith J.K., Spiller R.C. Colonic diverticular disease. Am. Fam. Physician. 2011;84(10):1163-64.
  7. Strate L.L., Modi R., Cohen E., Spiegel B.M. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. Am. J. Gastroenterol. 2012;07(10):1486-93.
  8. Meyer G.W. Diverticulosis is a disease of civilization. Clin. Gastroenterol. Hepatol. 2014;12:1580.
  9. Humes D.J. Changing epidemiology: does it increase our understanding? Dig. 2012; 30:6-11.
  10. Song J.H., Kim Y.S., Lee J.H., et al. Clinical characteristics of colonic diverticulosis in Korea: A prospective study. Korean J. Intern. Med. 2010;25:140-46.
  11. Fong S.S., Tan E.Y., Foo A., et al. The changing trend of diverticular disease in a developing nation. Colorectal. Dis. 2011;13:312-16.
  12. Воробьев Г.И. Основы колопроктологии. М., 2006. 432 с.
  13. Ивашкин В.Т., Шелыгин Ю.А., Ачкасов С.И., Васильев С.В., Григорьев Е.Г. и др. Рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России по диагностике и лечению взрослых больных дивертикулярной болезнью ободочной кишки. Росс. журн. гастроэнтерол, гепатол, колопроктол. 2016;1:65-80.
  14. Wehrman K., Frühmorgen P. Colondiverticulose. Diverticulitis. Freiburg, 1996. 38 p.
  15. Murphy T., Hunt R.H., Fried M.D., Krabshuis J.H. Diverticular disease. WGO-OMGE Global Guidelines. 2005:44-9.
  16. Шелыгин Ю.А., Благодарный Л.А. Справочник по колопроктологии. М., 2012. 608 с.
  17. Whiteway J., Morson B.C. Pathology of the ageing - Diverticular disease. Clin. Gastroenterol. 1985;14:829-46.
  18. Whiteway J., Morson B.C. Elastosis in diverticular disease of the sigmoid colon. Gut. 1985;26:258-66.
  19. Rosemar A., Ivarsson M.L., Borjesson L., et al. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease. Scand. J. Gastroenterol. 2007;42:215-20.
  20. Sandler R.S., Everhart J.E., Donowits M., et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500-15.
  21. Commane D.M., Arasaradnam R.P., Mills S., et al. Diet, ageing and genetic factors in the pathogenesis of diverticular disease. World J. Gastroenterol. 2009;5(20):2479-88.
  22. Filippini L. Divertikelkrankheit des Dickdarms. In: Schwiegk (Hrsg.) Handbuch der Inneren Medizin, Dritter Band, Teil 4.5. Auflage, Springer, Berlin-Heidelberg-New York, 1982. Р. 204-53.
  23. Aldoori W.H., Giovannucci E.L., Rockett H.R.H., et al. A prospective study of dietary fiber and symptomatic diverticular disease in men. J. Nutr. 1998;128:714-19.
  24. Schauer P.R., Ramos R., Ghiatas A.A., Sirinek K.R. Virulent diverticular disease in young obese men. Am. J. Surg. 1992;164(5):443-48.
  25. Dobbins C., Defontgalland D., Duthie G., Wattchow D.A. The relationship of obesity to the complications of diverticular disease. Colorectal Dis. 2006; 8(1):37-40.
  26. Aldoori W.H., Giovannucci E.L., Rimm E.B., et al. A prospective study of alcohol, smoking, caffeine, and the risk of symptomatic diverticular disease in men. Ann. Epidemiol. 1995; 5:221-28.
  27. Hjern F., Wolk A., Hâkansson N. Smoking and the risk of diverticular disease in women. Br. J. Surg. 2011;98(7):997-1002.
  28. Hinchey E.J., Schaal P.G.H., Richards G.K. Treatment of perforated diverticular disease of the colon. Adv. Surg. 1978;12:85-109.
  29. Hotz J. Divertikelkrankheit. Dtsch. Med. Wochenschr. 1983;108:1645-47.
  30. Hansen O., Stock W. Prophylaktische operation bei der divertikelkrankheit des kolons -stufenkonzept durch exakte stadieinteilung. Langenbecks Arch. Chir. 1999: (Suppl. II): 1257-60.
  31. Ünlü C., Daniels L., Vrouenraets B.C., Boermeester M.A. A systematic review of high-fibre dietary therapy in diverticular disease. Int. J. Colorectal. Dis. 2012;27:419-27.
  32. Bianchi M., Festa V., Moretti A., et al. Metaanalysis: longterm therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment. Pharmacol. Ther. 2011;33:902-10.
  33. Humes D.J., Spiller R.C. Review article: the pathogenesis and management of acute colonic diverticulitis. Aliment. Pharmacol. Ther. 2014;39:359-70.
  34. Di Mario F., Aragona G., Leandro G., et al. Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig. Dis. Sci. 2005;50:581-86.
  35. Kruis W., Meier E., Schumacher M., et al. German SAG-20 Study Group. Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon -a placebo-controlled study. Aliment. Pharmacol. Ther. 2013;37:680-90.
  36. Lahner E., Esposito G., Zullo A., et al. High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease. World J. Gastroenterol. 2012;18:5918-24.
  37. Annibale B., Maconi G., Lahner E., et al. Efficacy of Lactobacillus paracaseisub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study. Minerva Gastroenterol. Dietol. 2011;57:13-22.
  38. Ridgway P.F., Latif A., Shabbir J., et al. Randomized controlled trial of oral vs intravenous therapy for the clinically diagnosed acute uncomplicated diverticulitis. Colorectal. Dis. 2008;11:941-46.
  39. Москалев А.И. Клинико-морфофункциональные параллели при хронических осложнениях дивертикулярной болезни. Дисс. канд. мед. наук. М., 2007.
  40. Rafferty J., Shellito P., Hyman N.H., Buie W.D. Standards Committee of the American Society of Colon and Rectal Surgeons. Practice parameters for sigmoid diverticulities. Dis. Colon. Rectum. 2006;49:939-44.
  41. Bahadursingh A.M., Virgo K.S., Kaminski D.L., Longo W.E. Spectrum of disease and outcome of complicated diverticular disease. Am. J. Surg. 2003;186:696-701.
  42. Pietrzak A., Mik M., Bartnik W., Dziki A., Krokowicz P. Interdisciplinary consensus statement on the diagnosis and treatment of diverticular disease. Pol. Przegl. Chir. 2013;85:294-310.
  43. Kruis W., Germer C.T., Leifeld L. Diverticular disease: guidelines of the german society for gastroenterology, digestive and metabolic diseases and the German Society for General and Visceral Surgery. Digestion. 2014;90:190-207.
  44. Krokowicz L., Stojcev Z., Kaczmarek B.F., Kociemba W., Kaczmarek E., Walkowiak J., Krokowicz P., Drews M., Banasiewicz T. Microencapsulated sodium butyrate administered to patients with diverticulosisdecreasesincidenceof diverticulitis -a prospective randomized study. Int. J. Colorectal. Dis. 2014;29(3):387-93.
  45. Stollman N., Magowan S., Shanahan F., Quigley E.M. DIVA Investigator Group. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial. J. Clin. Gastroenterol. 2013;47:621-29.
  46. Parente F., Bargiggia S., Prada A., et al.; Gismi Study Group. Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration. Int. J. Colorectal. Dis. 2013;28:1423-31.
  47. Festa V., Spila Alegiani S., Chiesara F., Moretti A., Bianchi M., Dezi A., Traversa G., Koch M. Retrospective comparison of long-term ten-day/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis. Eur. Rev. Med. Pharmacol. Sci. 2017;21(6):1397-404.
  48. Tursi A., Brandimarte G., Giorgetti G.M., et al. Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int. J. Colorectal. Dis. 2007; 22:1103-108.
  49. Dughera L., Serra A.M., Battaglia E., et al. Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension. Minerva Gastroenterol. Dietol. 2004;50:149-53.
  50. Sheth A.A., Longo W., Floch M.H. Diverticular disease and diverticulitis. Am. J. Gastroenterol. 2008;103(6):1550-56.
  51. Tursi A., Danese S. Preventing diverticulitis recurrence by selecting the right therapy for a complex disease. Gastroenterology. 2014;147(4):733-36.
  52. Lanas A., Ponce J., Bignamini A., Mearin F One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: a proof-of-concept study. Dig. Liver Dis. 2013; 45(2):104-9.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies